background
molecular
detect
method
allow
simultan
detect
sever
infecti
agent
studi
assess
whether
coinfect
virus
compar
associ
increas
hospit
acut
respiratori
infect
method
prospect
enrol
cohort
pediatr
adult
particip
influenzalik
ill
mexico
clinic
inform
respiratori
sampl
collect
enrol
respiratori
virus
detect
multiplex
polymeras
chain
reaction
pcr
influenzaspecif
revers
transcript
pcr
assay
particip
follow
day
inclus
sever
diseas
measur
hospit
acut
respiratori
infect
compar
singl
dual
viral
infect
result
among
particip
studi
either
n
n
virus
detect
particip
rhinoviru
n
influenza
n
coronavirus
n
frequent
detect
virus
either
alon
coinfect
bocaviru
respiratori
syncyti
viru
rsv
metapneumoviru
rhinoviru
case
hospit
often
virus
bocavirusrhinoviru
case
hospit
often
rhinoviru
alon
bocaviru
alon
rsv
case
like
hospit
case
coinfect
rsv
parainfluenza
viru
coronaviru
metapneumoviru
case
hospit
often
coinfect
metapneumoviruscoronaviru
conclus
studi
detect
virus
significantli
increas
hospit
compar
singl
viru
infect
larger
studi
allow
distinguish
sequenti
simultan
infect
better
understand
role
viru
evolut
acut
respiratori
episod
current
estim
indic
lower
respiratori
tract
infect
lrti
fifth
lead
caus
death
world
account
million
death
etiolog
acut
respiratori
infect
divers
respiratori
virus
increasingli
recogn
import
caus
sever
respiratori
infect
introduct
molecular
detect
method
etiolog
larg
proport
acut
respiratori
infect
could
ascertain
increas
use
revers
transcript
polymeras
chain
reaction
rtpcr
molecular
method
allow
detect
respiratori
virus
larg
proport
case
addit
last
decad
previous
unrecogn
agent
human
metapneumoviru
hmpv
human
bocaviru
hbov
rhinoviru
c
sever
coronavirus
identifi
new
caus
respiratori
infect
use
current
avail
diagnost
techniqu
allow
detect
least
pathogen
major
patient
addit
rate
hospit
significantli
differ
base
viru
isol
mexican
children
year
age
younger
present
influenzalik
ill
ili
caus
human
respiratori
syncyti
viru
rsv
hmpv
shown
greater
risk
hospit
compar
virus
result
increas
use
molecular
detect
respiratori
virus
frequent
detect
virus
asymptomat
individu
need
clarifi
role
etiolog
lrti
addit
avail
diagnost
platform
allow
simultan
detect
mani
pathogen
result
identif
agent
larg
number
patient
respiratori
infect
use
molecular
method
detect
viral
coinfect
rel
rare
contrast
recent
studi
report
detect
viru
approxim
onefourth
patient
creat
new
opportun
studi
contribut
viru
develop
intens
durat
symptom
well
complic
eg
pneumonia
death
address
mani
studi
sought
determin
whether
coinfect
virus
contribut
sever
infect
studi
report
presenc
viru
associ
sever
infect
wherea
other
systemat
review
metaanalysi
studi
carri
children
year
age
associ
coinfect
increas
diseas
sever
found
need
studi
matter
identifi
variabl
result
studi
might
reflect
popul
includ
studi
definit
sever
use
virus
compar
particular
relev
definit
coinfect
mani
studi
compar
infect
specif
viru
infect
viru
assess
effect
presenc
virus
variou
combin
may
differenti
effect
sever
present
studi
investig
whether
sever
defin
hospit
acut
respiratori
infect
increas
virus
singl
viru
analyz
data
larg
prospect
ili
cohort
consecut
year
mexico
studi
analysi
base
data
hospitalbas
prospect
observ
cohort
studi
ili
present
analysi
includ
particip
enrol
studi
virus
detect
studi
carri
public
hospit
locat
mexico
citi
san
lui
particip
hospit
includ
gener
hospit
locat
mexico
citi
san
lui
tertiari
care
pediatr
hospit
tertiari
care
hospit
dedic
treatment
respiratori
disord
wherea
provid
medic
care
wide
rang
medic
specialti
adult
children
seek
medic
attent
ili
defin
respiratori
symptom
eg
cough
dyspnea
plu
system
symptom
eg
fever
malais
invit
particip
protocol
clinicaltrialsgov
identifi
enrol
followup
telephon
facetofac
interview
perform
day
visit
happen
day
inclus
studi
protocol
approv
ethic
committe
particip
institut
particip
guardian
sign
inform
consent
assent
form
pertin
nasopharyng
swab
multipl
pcr
pathogen
detect
obtain
enrol
sampl
store
transport
media
site
site
locat
mexico
citi
sent
daili
central
facil
hadv
bacteria
bordetella
pertussi
chlamydophila
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
assay
ad
cov
hbov
influenza
remov
influenza
report
manufactur
analyt
limit
detect
assay
vari
copi
per
reaction
target
sampl
test
origin
kit
subsequ
test
hbov
detect
use
virusspecif
primer
addit
sampl
test
realtim
rtpcr
influenza
follow
center
diseas
control
prevent
cdc
protocol
particip
hospit
day
studi
followup
consid
sever
diseas
hospit
defin
particip
admit
hospit
remain
emerg
depart
least
hour
particip
detect
bacteri
pathogen
bordetella
pertussi
chlamydophila
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
viru
virus
exclud
comorbid
defin
follow
chronic
obstruct
pulmonari
diseas
cardiovascular
diseas
diabet
mellitu
previou
use
system
steroid
obes
overweight
underweight
analysi
group
similar
genera
virus
examin
frequent
group
virus
isol
influenza
b
group
influenza
hmpv
hpiv
rsv
rv
hadv
cov
hbov
comparison
baselin
factor
made
hospit
nonhospit
group
potenti
risk
factor
categor
group
categori
chisquar
statist
use
make
univari
comparison
risk
factor
logist
regress
model
use
compar
hospit
pair
virus
combin
virus
combin
particip
analyz
logist
regress
model
includ
sex
age
group
categori
day
sinc
symptom
onset
group
categori
comorbid
yesno
odd
ratio
confid
interv
calcul
particip
includ
studi
interview
viru
isol
sampl
addit
exclud
reason
bacteri
infect
subject
miss
covari
inform
subject
virus
subject
final
data
set
particip
particip
hospit
year
old
year
old
male
tabl
hospit
case
die
viru
die
virus
detect
tabl
show
distribut
particip
singl
viru
diagnosi
across
covari
use
logist
regress
model
influenza
hpiv
cov
rv
detect
frequent
particip
year
old
wherea
rsv
hmpv
hadv
hbov
common
children
year
old
one
viru
detect
virus
detect
particip
tabl
rv
n
influenza
n
cov
n
frequent
detect
virus
either
alon
coinfect
frequent
combin
influenzacov
dual
infect
influenza
found
combin
agent
particip
dual
infect
subject
combin
virus
number
small
perform
statist
analys
analyz
descript
subject
virus
detect
rv
influenza
cov
combin
virus
occur
often
subject
influenza
hmpv
hbov
adjust
odd
ratio
or
hospit
rate
virus
includ
studi
shown
figur
particip
infect
hbov
like
hospit
infect
influenza
cov
hpiv
rv
figur
hadv
hmpv
rsv
similar
statist
signific
result
particip
infect
rsv
like
hospit
compar
case
influenza
cov
rv
hpiv
hadv
lesser
extent
statist
signific
hmpv
figur
particip
hmpv
like
hospit
compar
case
influenza
cov
rv
statist
significantli
differ
compar
hpiv
hadv
figur
hpiv
case
like
hospit
compar
case
influenza
cov
lesser
extent
hadv
assess
point
estim
figur
although
none
comparison
statist
signific
particip
hadv
like
hospit
compar
case
influenza
cov
assess
point
estim
although
neither
comparison
reach
statist
signific
figur
particip
rv
like
hospit
compar
cov
case
figur
although
statist
signific
cov
case
less
like
hospit
compar
influenza
figur
figur
show
comparison
influenza
case
alreadi
describ
virus
isol
combin
rsvhpiv
covhmpv
covrsv
less
like
hospit
particip
infect
individu
virus
figur
point
estim
individu
virus
hmpv
rv
demonstr
higher
likelihood
patient
hospit
combin
confid
interv
includ
figur
particip
hbovrv
like
hospit
rv
hospit
frequent
hbov
alon
figur
point
estim
sever
covrv
greater
individu
cov
rv
alon
figur
confid
interv
includ
confid
interv
combin
includ
point
estim
indic
combin
could
sever
singl
agent
figur
r
report
impact
multipl
viral
infect
frequent
avail
pcr
assay
detect
multipl
pathogen
report
analyz
data
group
combin
compar
group
differ
singl
virus
result
variabl
interpret
larg
studi
ili
multipathogen
pcr
assay
perform
sampl
particip
size
cohort
allow
suffici
number
particip
variou
viru
combin
perform
separ
analys
viru
combin
examin
whether
viru
combin
increas
sever
individu
virus
result
highlight
import
carri
separ
analys
data
demonstr
sever
diseas
higher
specif
virus
eg
hbov
rsv
hmpv
howev
combin
dual
infect
significantli
wors
individu
virus
furthermor
class
effect
appear
infect
viru
increas
sever
diseas
mani
confid
interv
combin
includ
differ
comparison
individu
virus
base
sole
point
estim
may
chang
increas
number
particip
appear
pattern
indic
lead
govern
effect
viru
combin
exampl
combin
covrsv
figur
panel
c
cov
case
covrsv
case
less
sever
case
rsv
moreov
sever
covrsv
case
differ
cov
case
could
indic
cov
lead
govern
agent
combin
similarli
hbov
may
govern
rv
combin
virus
panel
j
rv
govern
cov
panel
k
influenza
govern
hbov
panel
n
rv
govern
rsv
panel
p
confid
interv
around
combin
often
larg
includ
interpret
conclus
could
differ
larger
number
particip
studi
howev
pattern
observ
point
estim
suggest
govern
effect
describ
warrant
studi
one
explan
govern
result
virolog
test
done
particip
distinguish
sequenti
infect
virus
simultan
infect
virus
possibl
result
could
reflect
sequenti
infect
rather
simultan
infect
symptom
hospit
could
result
virus
sampl
collect
time
respect
cours
ill
would
import
factor
studi
carri
particip
ili
viral
coinfect
detect
frequent
sampl
obtain
first
day
symptom
onset
compar
obtain
day
thu
plausibl
detect
coinfect
might
result
prolong
shed
viru
subsequ
infect
second
viru
also
could
reflect
reduc
abil
second
viru
replic
due
alreadi
initi
host
respons
product
interferon
result
initi
viral
infect
interfer
viru
anoth
viru
shown
occur
vitro
epidemiolog
studi
suggest
circul
viru
might
affect
circul
anoth
viru
commun
overal
previou
studi
shown
similar
sever
singl
infect
compar
mix
infect
howev
studi
shown
signific
differ
specif
combin
virus
singl
virus
exampl
case
coinfect
rsvrv
rsvhbov
ill
appear
sever
case
rsv
hbov
infect
alon
result
rsvrv
follow
pattern
suffici
data
studi
combin
rsvhbov
analysi
show
particip
detect
influenza
viru
less
like
requir
hospit
particip
virus
detect
observ
despit
fact
studi
includ
winter
season
sever
wave
influenza
regist
mexico
result
could
deriv
inclus
influenza
subtyp
analysi
lower
hospit
rate
particip
influenza
viru
infect
compar
virus
may
also
explain
influenza
vaccin
sinc
influenza
vaccin
coverag
mexico
high
influenza
vaccin
report
reduc
influenza
hospit
unfortun
possibl
obtain
detail
data
regard
influenza
vaccin
statu
studi
particip
assess
also
found
singl
viru
comparison
hbov
rsv
hmpv
associ
sever
infect
rsv
hmpv
find
consist
report
show
virus
lead
caus
lrti
children
adult
contrast
role
hbov
caus
sever
infect
less
well
establish
hbov
infect
common
frequent
found
asymptomat
particip
pathogen
role
viru
question
children
higher
viral
load
tend
sever
infect
longer
hospit
durat
found
coinfect
virus
less
frequent
lower
viral
load
howev
children
daycar
viral
load
appar
associ
sever
ill
also
might
reflect
challeng
reproduc
measur
viral
load
secret
studi
suggest
hbov
frequent
present
children
asymptomat
chronic
infect
low
viral
load
wherea
infect
high
viral
load
present
may
associ
sever
infect
requir
hospit
studi
measur
viral
load
unclear
hbov
particip
repres
sampl
highvir
load
particip
includ
asymptomat
particip
hbov
strength
studi
includ
larg
number
particip
consist
baselin
test
followup
limit
includ
definit
sever
hospit
surrog
actual
patient
health
statu
patient
may
hospit
caus
respiratori
ill
worsen
comorbid
observ
highrisk
particip
social
reason
studi
done
use
direct
measur
patient
health
statu
intens
durat
particip
symptom
complic
eg
pneumonia
develop
symptom
scale
influenza
flupro
part
studi
could
use
futur
studi
adjust
odd
ratio
log
scale
presenc
chronic
underli
condit
import
factor
associ
risk
develop
sever
respiratori
infect
addit
possibl
chronic
condit
may
increas
risk
acquir
infect
multipl
pathogen
recent
studi
report
patient
coinfect
caus
differ
influenza
viru
strain
like
underli
cardiovascular
disord
singl
influenza
infect
howev
differ
observ
preval
underli
condit
although
studi
found
higher
preval
chronic
disord
patient
multipl
viral
pathogen
appear
limit
specif
condit
differ
observ
disord
addit
mani
studi
found
associ
presenc
chronic
disord
detect
multipl
virus
main
object
studi
determin
codetect
virus
associ
wors
outcom
analyz
factor
may
led
acquisit
virus
nevertheless
analysi
includ
presenc
chronic
condit
covari
order
account
potenti
confound
previou
analysi
limit
children
year
age
sever
singl
virus
compar
result
similar
find
singl
virus
present
studi
major
studi
focus
children
effect
mix
viral
infect
adult
less
clear
one
strength
analysi
studi
popul
includ
pediatr
adult
symptomat
particip
although
comparison
result
estim
wide
confid
interv
interpret
base
point
estim
reveal
sever
pattern
could
hypothesisgener
futur
studi
result
suggest
gener
viru
detect
pcr
respiratori
sampl
increas
sever
diseas
ili
assess
differ
hospit
rate
mix
respiratori
infect
necessari
carri
analys
specif
combin
virus
virus
detect
appear
clinic
sever
respiratori
infect
defin
hospit
may
associ
agent
futur
studi
larger
number
particip
design
distinguish
sequenti
simultan
infect
use
direct
measur
patient
health
statu
help
defin
role
viru
evolut
acut
respiratori
episod
